Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/09/2003WO2003082252A1 Hfa-suspension formulations containing an anticholinergic
10/09/2003WO2003082247A2 Drug microparticles
10/09/2003WO2003082246A1 Stabilized natural cannabinoid formulation
10/09/2003WO2003082245A1 Methods of using lamellar bodies for therapeutic purposes
10/09/2003WO2003082244A2 Hfa-suspension formulation of an anhydrate
10/09/2003WO2003082242A2 Highly aqueous liquid carrier formulations
10/09/2003WO2003082213A2 Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
10/09/2003WO2003082209A2 Cochleates made with purified soy phosphatidylserine
10/09/2003WO2003082207A2 Volume efficient controlled release dosage form
10/09/2003WO2003082195A2 Protamine-adenoviral vector complexes and methods of use
10/09/2003WO2003082193A2 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082163A1 Adherent n,o-carboxymethylchitosan drug delivery devices for moist tissue and methods of their use
10/09/2003WO2003082139A1 Dispensing apparatus and cartridge
10/09/2003WO2003082117A1 Device and method for quantifying bodies by means of ultrasound
10/09/2003WO2003082019A2 Peptides with anti-hypertensive properties
10/09/2003WO2003055445A3 Compositions and methods for enhancing corticosteriod delivery
10/09/2003WO2003054208A3 Method of modulating release of saccharides and uses thereof
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003049667A3 The method of treating cancer
10/09/2003WO2003047620A3 Compositions and methods for producing vascular occlusion
10/09/2003WO2003040686A3 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
10/09/2003WO2003026621A3 Method for making an oral pharmaceutical product with tell-tale agents, in particular of taste and resulting product
10/09/2003WO2003026617A3 (ester)-lysolecithins in liposomes
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003005959A3 Amphiphilic star-like macromolecules for drug delivery
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002078747A3 Pregabalin lactose conjugates
10/09/2003WO2002060955A3 Modified antibodies and methods of use
10/09/2003WO2002056905A3 Molecular antigen array
10/09/2003WO2002043769A3 Neutral and anionic colloidal particles for gene delivery
10/09/2003WO2002029072A3 Targetting molecules for adenoviral vectors
10/09/2003US20030191291 Synthetic erythropoiesis stimulating proteins
10/09/2003US20030191286 Purification and characterization of soluble human HLA proteins
10/09/2003US20030191187 Aqueous solution containing phosphate; adjustment pH
10/09/2003US20030191180 Pharmaceutical compositions
10/09/2003US20030191179 Methods for administration of paclitaxel
10/09/2003US20030191159 Antisecretory agents; antiulcer agents; adjust absorption
10/09/2003US20030191157 Injections
10/09/2003US20030191148 Macrolides
10/09/2003US20030191093 Pharmaceutical compositions comprising active vitamin D compounds
10/09/2003US20030191090 Anemia therapy; hydrogenation dextrin; reacting with ferric salt; complexing
10/09/2003US20030191081 Polynucleotides; gene therapy; vaccines; efficient gene expression; administering to muscles
10/09/2003US20030191079 Methods for treating and preventing infectious disease
10/09/2003US20030191075 Modulation of gene expression of nucleic acids; sterol binding to oligonucleotides
10/09/2003US20030191056 Immobilization onto polyoxyethylene glycol
10/09/2003US20030191052 Infection therapy; binding of mannan lecithin to protein
10/09/2003US20030191043 Methods and formulations for enhancing the dissolution of a solid material in liquid
10/09/2003US20030190676 In which covalently modified antibody takes on the binding specificity of a targeting agent
10/09/2003US20030190635 RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
10/09/2003US20030190628 Beads, preparing method for the same, flow cytometer and program
10/09/2003US20030190387 Obtained by hydrolyzing pyrodextrin with amylase and debranching enzyme; (sugar-free) chewing gum
10/09/2003US20030190380 Heating Aloe vera gel to 35-80 degrees C, adding 0.01-2.0% tocotrienol/tocopherol blend, cooling
10/09/2003US20030190366 Particle formation
10/09/2003US20030190364 Biological affinity based delivery systems
10/09/2003US20030190360 Chronotherapeutic pharmaceutical formulation comprising core containing active agent and delayed release compression coating comprising a natural or synthetic gum applied onto surface of core
10/09/2003US20030190357 Compositions for delivery of a cortisol antagonist
10/09/2003US20030190343 Palatable pharmaceutical compositions for companion animals
10/09/2003US20030190340 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents
10/09/2003US20030190334 1S-(1 alpha ,3 alpha ,4 beta ))-2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl)-6H-puri n-6-one to treat hepatitis B virus infection
10/09/2003US20030190331 Vaccine composition and stabilisation method
10/09/2003US20030190316 Comprises humanized anti-interleukin-6 receptor antibody in glycine and/or histidine buffer
10/09/2003US20030190311 Immunoglobulins; fusion proteins; vaccines
10/09/2003US20030190310 Primary package containing a low molecular weight peptide-based thrombin inhibitors sealed with a bromobutyl rubber stopper or plunger
10/09/2003US20030190307 Stable liquid interferon formulations
10/09/2003US20030190306 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constituent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/09/2003US20030190304 Pegylation reagents and compounds formed therewith
10/09/2003US20030190291 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
10/09/2003US20030190289 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
10/09/2003US20030190286 Propellant free buccal spray composition for transmucosal administration of pharmacologically active compound comprising 0.001-60 percent by weight immunosuppressants, mucolytics, glucocorticoids and 30-99 percent polar solvent
10/09/2003US20030190284 Agglomerated particles for aerosol drug delivery
10/09/2003US20030188740 Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings
10/09/2003US20030188679 Powdered mannitol and mannitol-containing compositions
10/09/2003CA2519642A1 A composition and method for killing of tumours
10/09/2003CA2481236A1 Volume efficient controlled release dosage form
10/09/2003CA2481214A1 Viscous preparation for dental use containing basic fibroblast growth factor
10/09/2003CA2480632A1 Drug delivery particle
10/09/2003CA2480630A1 Tissue treatment
10/09/2003CA2480377A1 Drug microparticles
10/09/2003CA2480270A1 Stabilized natural cannabinoid formulation
10/09/2003CA2480265A1 Cochleates made with purified soy phosphatidylserine
10/09/2003CA2479995A1 Dispensing apparatus and cartridge
10/09/2003CA2479915A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2479914A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003CA2479807A1 Antimicrobial polymer conjugates
10/09/2003CA2479759A1 Protamine-adenoviral vector complexes and methods of use
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479148A1 A method for treating carrier particles and its use
10/09/2003CA2478470A1 Solubilization of weak bases
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003CA2477734A1 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003CA2477268A1 Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
10/08/2003EP1350556A1 Multiple emulsions
10/08/2003EP1350525A2 Matrix-free osteogenic devices, implants and methods thereof
10/08/2003EP1350523A2 Therapeutic conjugates inhibiting vascular smooth muscle cells
10/08/2003EP1350522A1 Topical anesthesia compositions
10/08/2003EP1350519A1 Drugs and foods improving the quality of life and process for producing the same
10/08/2003EP1350518A1 Prolonged release of GM-CSF
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
1 ... 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 ... 1712